These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1054 related items for PubMed ID: 9809558

  • 1. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA, Harper JD, Lansbury PT.
    Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
    [Abstract] [Full Text] [Related]

  • 2. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P.
    Proc Natl Acad Sci U S A; 2002 Aug 06; 99(16):10813-8. PubMed ID: 12122208
    [Abstract] [Full Text] [Related]

  • 3. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ.
    Mov Disord; 2004 Feb 06; 19(2):162-70. PubMed ID: 14978671
    [Abstract] [Full Text] [Related]

  • 4. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H.
    Ann Neurol; 2000 Apr 06; 47(4):521-3. PubMed ID: 10762166
    [Abstract] [Full Text] [Related]

  • 5. A Drosophila model of Parkinson's disease.
    Feany MB, Bender WW.
    Nature; 2000 Mar 23; 404(6776):394-8. PubMed ID: 10746727
    [Abstract] [Full Text] [Related]

  • 6. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA, Harper JD, Lansbury PT.
    Biochemistry; 2000 Mar 14; 39(10):2552-63. PubMed ID: 10704204
    [Abstract] [Full Text] [Related]

  • 7. Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter.
    Matsuoka Y, Vila M, Lincoln S, McCormack A, Picciano M, LaFrancois J, Yu X, Dickson D, Langston WJ, McGowan E, Farrer M, Hardy J, Duff K, Przedborski S, Di Monte DA.
    Neurobiol Dis; 2001 Jun 14; 8(3):535-9. PubMed ID: 11442360
    [Abstract] [Full Text] [Related]

  • 8. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T.
    Rinsho Shinkeigaku; 1999 Dec 14; 39(12):1285-6. PubMed ID: 10791099
    [Abstract] [Full Text] [Related]

  • 9. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
    Moussa CE, Wersinger C, Tomita Y, Sidhu A.
    Biochemistry; 2004 May 11; 43(18):5539-50. PubMed ID: 15122920
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.
    Brain; 2005 Nov 11; 128(Pt 11):2654-64. PubMed ID: 16000336
    [Abstract] [Full Text] [Related]

  • 12. Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions.
    Tsuchiya K, Tajima H, Kuwae T, Takeshima T, Nakano T, Tanaka M, Sunaga K, Fukuhara Y, Nakashima K, Ohama E, Mochizuki H, Mizuno Y, Katsube N, Ishitani R.
    Eur J Neurosci; 2005 Jan 11; 21(2):317-26. PubMed ID: 15673432
    [Abstract] [Full Text] [Related]

  • 13. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA.
    Acta Neuropathol; 2003 Sep 11; 106(3):191-201. PubMed ID: 12845452
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H.
    J Neurochem; 2004 Oct 11; 91(2):451-61. PubMed ID: 15447678
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
    Shirakashi Y, Kawamoto Y, Tomimoto H, Takahashi R, Ihara M.
    Acta Neuropathol; 2006 Dec 11; 112(6):681-9. PubMed ID: 16957925
    [Abstract] [Full Text] [Related]

  • 19. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.
    Engelender S, Kaminsky Z, Guo X, Sharp AH, Amaravi RK, Kleiderlein JJ, Margolis RL, Troncoso JC, Lanahan AA, Worley PF, Dawson VL, Dawson TM, Ross CA.
    Nat Genet; 1999 May 11; 22(1):110-4. PubMed ID: 10319874
    [Abstract] [Full Text] [Related]

  • 20. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
    Liu IH, Uversky VN, Munishkina LA, Fink AL, Halfter W, Cole GJ.
    Glycobiology; 2005 Dec 11; 15(12):1320-31. PubMed ID: 16037493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.